Brookstone Capital Management Abbott Laboratories Transaction History

Brookstone Capital Management

$6.01 Billion
Q3 2024

A detailed history of Brookstone Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Brookstone Capital Management holds 42,762 shares of ABT stock, worth $5.04 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

42,762

Previous 41,771 2.37%

Holding current value

$5.04 Million

Previous $4.34 Million 12.33%

% of portfolio

0.08%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$100.07 - $118.13 $99,169 - $117,066	991 Added 2.37%	42,762 $4.88 Million
Q2 2024 Jul 18, 2024	BUY	$100.73 - $112.44 $158,448 - $176,868	1,573 Added 3.91%	41,771 $4.34 Million
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $494,044 - $545,650	-4,511 Reduced 10.09%	40,198 $4.57 Million
Q4 2023 Jan 11, 2024	BUY	$90.19 - $110.4 $772,657 - $945,796	8,567 Added 23.7%	44,709 $4.92 Million
Q3 2023 Oct 20, 2023	SELL	$95.53 - $114.62 $52,063 - $62,467	-545 Reduced 1.49%	36,142 $3.5 Million
Q2 2023 Jul 11, 2023	BUY	$100.78 - $112.29 $268,175 - $298,803	2,661 Added 7.82%	36,687 $4 Million
Q1 2023 Apr 18, 2023	SELL	$96.86 - $114.01 $265,396 - $312,387	-2,740 Reduced 7.45%	34,026 $3.45 Million
Q4 2022 Jan 09, 2023	BUY	$95.06 - $111.52 $462,276 - $542,321	4,863 Added 15.24%	36,766 $0
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $31,640 - $36,633	-327 Reduced 1.01%	31,903 $3.19 Million
Q2 2022 Jul 11, 2022	SELL	$102.07 - $123.37 $10,309 - $12,460	-101 Reduced 0.31%	32,230 $3.52 Million
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $36,486 - $44,492	-320 Reduced 0.98%	32,331 $3.88 Million
Q4 2021 Jan 11, 2022	BUY	$115.53 - $141.46 $144,296 - $176,683	1,249 Added 3.98%	32,651 $4.43 Million
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $1.24 Million - $1.37 Million	-10,649 Reduced 25.32%	31,402 $3.67 Million
Q2 2021 Jul 14, 2021	BUY	$105.79 - $124.53 $2.05 Million - $2.41 Million	19,376 Added 85.45%	42,051 $4.99 Million
Q1 2021 Apr 16, 2021	BUY	$108.84 - $128.23 $879,536 - $1.04 Million	8,081 Added 55.37%	22,675 $2.72 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $39,060 - $42,564	372 Added 2.62%	14,594 $1.6 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $603,266 - $732,622	6,583 Added 86.18%	14,222 $1.55 Million
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $585,530 - $749,406	-7,647 Reduced 50.03%	7,639 $698,000
Q1 2020 Apr 14, 2020	SELL	$62.82 - $91.86 $284,260 - $415,666	-4,525 Reduced 22.84%	15,286 $1.21 Million
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $161,259 - $179,519	2,054 Added 11.57%	19,811 $1.72 Million
Q3 2019 Oct 18, 2019	BUY	$81.84 - $88.74 $5,483 - $5,945	67 Added 0.38%	17,757 $1.49 Million
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $11,952 - $13,940	-164 Reduced 0.92%	17,690 $1.49 Million
Q1 2019 Apr 18, 2019	BUY	$66.22 - $80.06 $12,648 - $15,291	191 Added 1.08%	17,854 $1.43 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $193,139 - $218,799	2,946 Added 20.02%	17,663 $1.28 Million
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $205,112 - $247,443	3,373 Added 29.73%	14,717 $1.08 Million
Q2 2018 Aug 06, 2018	BUY	$57.57 - $63.54 $84,052 - $92,768	1,460 Added 14.77%	11,344 $692,000
Q1 2018 Apr 23, 2018	BUY	$56.27 - $63.62 $153,392 - $173,428	2,726 Added 38.08%	9,884 $592,000
Q4 2017 Feb 07, 2018	BUY	$53.68 - $57.47 $173,493 - $185,743	3,232 Added 82.32%	7,158 $408,000
Q3 2017 Oct 31, 2017	SELL	$48.06 - $53.64 $12,063 - $13,463	-251 Reduced 6.01%	3,926 $209,000
Q2 2017 Aug 08, 2017	BUY	N/A	4,177	4,177 $203,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Account

Brookstone Capital Management Abbott Laboratories Transaction History